• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.

作者信息

Bungard T J, Ghali W A, McAlister F A, Buchan A M, Cave A J, Hamilton P G, Mitchell L B, Shuaib A, Teo K K, Tsuyuki R T

出版信息

CMAJ. 2001 Aug 7;165(3):301-2.

PMID:11517646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC81330/
Abstract
摘要

相似文献

1
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.医生对非瓣膜性心房颤动患者使用华法林的获益与风险的认知。
CMAJ. 2001 Aug 7;165(3):301-2.
2
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.非瓣膜性心房颤动患者华法林处方障碍的相对重要性。
Can J Cardiol. 2003 Mar 15;19(3):280-4.
3
Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.进退两难——权衡华法林对老年房颤患者的风险与潜在益处。
Age Ageing. 2004 Nov;33(6):544-7. doi: 10.1093/ageing/afh211.
4
Bleeding risk on warfarin among elderly patients with atrial fibrillation.老年房颤患者服用华法林后的出血风险
J Am Coll Cardiol. 2010 Mar 2;55(9):932; author reply 932-3. doi: 10.1016/j.jacc.2009.11.037.
5
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
6
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.医生对老年房颤患者预防中风使用口服抗凝剂和抗血小板药物的态度。
Arch Intern Med. 1991 Oct;151(10):1950-3.
7
Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?临床问题。对于非瓣膜性心房颤动患者，联合使用阿司匹林和华法林是否能降低中风风险？
J Fam Pract. 2004 Jul;53(7):570-5.
8
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.老年房颤患者（包括有跌倒和/或早期痴呆症的患者）预防卒中的抗凝治疗：一项单中心、回顾性、观察性研究。
Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.
9
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
10
Stroke in heart failure: atrial fibrillation revisited?心力衰竭中的中风：重新审视心房颤动？
J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002.

引用本文的文献

1
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.非瓣膜性心房颤动的拉丁美洲国家患者的卒中预防：来自 GARFIELD-AF 注册研究的结果。
Clin Cardiol. 2019 May;42(5):553-560. doi: 10.1002/clc.23176. Epub 2019 Apr 9.
2
Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial.改善基层医疗中房颤患者的卒中预防治疗：一项实用的整群随机试验方案
Implement Sci. 2016 Dec 3;11(1):159. doi: 10.1186/s13012-016-0523-2.
3
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.使用心房颤动决策支持工具进行心房颤动的血栓预防：性别和年龄的影响。
J Am Geriatr Soc. 2016 May;64(5):1054-60. doi: 10.1111/jgs.14099.
4
Evaluating the Usability and Perceived Impact of an Electronic Medical Record Toolkit for Atrial Fibrillation Management in Primary Care: A Mixed-Methods Study Incorporating Human Factors Design.评估用于基层医疗中房颤管理的电子病历工具包的可用性和感知影响：一项纳入人因设计的混合方法研究
JMIR Hum Factors. 2016 Feb 17;3(1):e7. doi: 10.2196/humanfactors.4289.
5
Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.农村居住环境对非瓣膜性心房颤动患者华法林使用及临床事件的影响：一项基于加拿大人群的研究
PLoS One. 2015 Oct 14;10(10):e0140607. doi: 10.1371/journal.pone.0140607. eCollection 2015.
6
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study.华法林在伴有心房颤动的缺血性中风患者中的真实世界有效性：来自以患者为中心的中风患者偏好与有效性研究（PROSPER）的观察性分析。
BMJ. 2015 Jul 31;351:h3786. doi: 10.1136/bmj.h3786.
7
Improving outpatient warfarin use for hospitalized patients with atrial fibrillation.改善房颤住院患者门诊华法林的使用情况。
Pharm Pract (Granada). 2008 Jan;6(1):43-50. doi: 10.4321/s1886-36552008000100007. Epub 2008 Mar 10.
8
Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.对提出的华法林处方用于心房颤动的既定障碍的影响：对加拿大医生的调查。
Thromb J. 2014 Jun 23;12:13. doi: 10.1186/1477-9560-12-13. eCollection 2014.
9
Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse.关于埃菲德等人的胶囊评论，确定药物滥用患者抗凝治疗的风险。
J Gen Intern Med. 2013 Oct;28(10):1351. doi: 10.1007/s11606-013-2486-1.
10
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation.国际上心力衰竭合并心房颤动患者口服抗凝药物的使用差异。
Am Heart J. 2012 May;163(5):804-11. doi: 10.1016/j.ahj.2012.02.008. Epub 2012 Mar 27.

本文引用的文献

1
Why do patients with atrial fibrillation not receive warfarin?为什么心房颤动患者没有接受华法林治疗？
Arch Intern Med. 2000 Jan 10;160(1):41-6. doi: 10.1001/archinte.160.1.41.
2
The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.阿司匹林对心房颤动患者的疗效。来自3项随机试验的汇总数据分析。心房颤动研究人员。
Arch Intern Med. 1997 Jun 9;157(11):1237-40.
3
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.心房颤动患者中风的危险因素及抗血栓治疗的疗效。五项随机对照试验汇总数据的分析。
Arch Intern Med. 1994 Jul 11;154(13):1449-57.
4
Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.医生对老年非瓣膜性心房颤动抗凝治疗的态度。
Arch Intern Med. 1995 Feb 13;155(3):277-81.
5
Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project.
Arch Intern Med. 1990 Jan;150(1):83-6.